← SynDRA
P5091
SynDRA canonical compound SYN1970080 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | USP7 |
|---|
| Mechanism of action | ubiquitin specific protease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ubiquitin specific protease inhibitor
- USP7 INHIBITOR
Cross-references
Synonyms
- P005091
- 1-(5-(2,3-dichlorophenylthio)-4-nitrothiophen-2-yl)ethanone
- P 5091
- 1-[5-(2,3-Dichloro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone
- CHEMBL2159495
- P5091 (P005091)
- 1-[5-(2,3-dichlorophenyl)sulfanyl-4-nitrothiophen-2-yl]ethanone
- 1-(5-((2,3-Dichlorophenyl)thio)-4-nitrothiophen-2-yl)ethanone
- Cyto5D7
- C12H7Cl2NO3S2
- SCHEMBL2681288
- DTXSID90384841
- 1-[5-[(2,3-Dichlorophenyl)thio]-4-nitro-2-thienyl]ethanone
- HMS3653E09
- HMS3743M19
- ZINC125366
- BCP07750
- EX-A2120
- BDBM50393437
- MFCD00123202
- s7132
- AKOS024458314
- CCG-240421
- CS-1445
- MCULE-6661883192
- QC-8200
- SB19505
- AC-32692
- AK270202
- BS-17872
- DA-40897
- HY-15667
- FT-0714931
- SW219710-1
- Y1893
- J3.502.625H
- P-05091
- P005091(P5091)
- P-005091
Look up P5091 in the interactive SynDRA portal →